发病机制
医学
信号转导
免疫学
癌症研究
遗传学
生物
作者
Alexandros A. Drosos,Aliki I. Venetsanopoulou,Paraskevi V. Voulgari
标识
DOI:10.1080/1744666x.2025.2542360
摘要
JAKi are useful in the treatment of SpA and are recommended by international authorities in patients suffering from SpA. Despite the promising results, ongoing research is essential to assess the benefit-risk profile of JAKi in SpA.
科研通智能强力驱动
Strongly Powered by AbleSci AI